Multiparameter battery state estimator based on adaptive direct solution different equation.docx

上传人:b****5 文档编号:29012939 上传时间:2023-07-20 格式:DOCX 页数:99 大小:64.07KB
下载 相关 举报
Multiparameter battery state estimator based on adaptive direct solution different equation.docx_第1页
第1页 / 共99页
Multiparameter battery state estimator based on adaptive direct solution different equation.docx_第2页
第2页 / 共99页
Multiparameter battery state estimator based on adaptive direct solution different equation.docx_第3页
第3页 / 共99页
Multiparameter battery state estimator based on adaptive direct solution different equation.docx_第4页
第4页 / 共99页
Multiparameter battery state estimator based on adaptive direct solution different equation.docx_第5页
第5页 / 共99页
点击查看更多>>
下载资源
资源描述

Multiparameter battery state estimator based on adaptive direct solution different equation.docx

《Multiparameter battery state estimator based on adaptive direct solution different equation.docx》由会员分享,可在线阅读,更多相关《Multiparameter battery state estimator based on adaptive direct solution different equation.docx(99页珍藏版)》请在冰豆网上搜索。

Multiparameter battery state estimator based on adaptive direct solution different equation.docx

Multiparameterbatterystateestimatorbasedonadaptivedirectsolutiondifferentequation

Newtestmethodwiththeaimtoevaluatethetribologyinpowderdiecompaction.►Testmethodutilizesacommercialscratchtester.►Smalltestsamplespromotepost-testmicroscopyandsurfaceanalysis.►Tribo-inducedmechanismsaremonitoredbyfrictionandacousticemissionsignals.►Promisingscreeningtestforcandidatedietoolmaterials.

267

CornealRefractivePowerandItsAssociationswithOcularandGeneralParameters:

TheCentralIndiaEyeandMedicalStudy  OriginalResearchArticle

Ophthalmology,Volume118,Issue9,September2011,Pages1805-1811

JostB.Jonas,VinayNangia,AjitSinha,RajeshGupta

 Closepreview  |  Supplementarycontent

  |  Relatedarticles  |  Relatedreferenceworkarticles    

AbstractAbstract|Figures/TablesFigures/Tables|ReferencesReferences

Purpose

Toinvestigatethenormaldistributionofcornealrefractivepower(CRP)anditsassociationswithotherocularandsystemicparametersintheCentralIndianpopulation.

Design

Population-basedstudy.

Participants

TheCentralIndiaEyeandMedicalStudyisapopulation-basedstudyperformedinaruralregionofCentralIndia.Thestudycomprised4711subjectsaged30+years.

Methods

Adetailedophthalmicandmedicalexaminationwasperformed.HorizontalandverticalCRPweremeasuredusinganon-automatickeratometer.

MainOutcomeMeasures

Cornealrefractivepower.

Results

Afterexcludingpseudophakicoraphakiceyes,keratometricmeasurementswereavailableon9024eyesof4617studyparticipants(98.0%)withameanageof49.1±13.2years(range,30–100years)andameanrefractiveerrorof−0.20±1.52diopters(D).MeanhorizontalCRPwas44.60±1.68D(mean±standarddeviation;range,36.5–52.0D),andverticalCRPwas44.62±1.74D(range,37.75–52.0D)withnosignificantdifferencebetweenbothparameters(P=0.27).Inmultivariateanalysis,CRPwassignificantly(P<0.001)associatedwiththesystemicparametersofincreasingage(P<0.001),lowerlevelofeducation(P=0.02),andlowerbodyheight(P<0.001),andwiththeocularparametersofthinnercentralcornealthickness(P<0.001),deeperanteriorchamber(P<0.001),shorteraxiallength(P<0.001),andmyopicrefractiveerror(P<0.001).TheresultsremainedunchangedifeyeswithCRP≥48Dwereexcluded.

Conclusions

HorizontalCRPincreasedwithhigherage,lowerlevelofeducation,lowerbodyheight,thinnercentralcornea,deeperanteriorchamber,shorteraxiallength,andmyopicrefractiveerror.Theassociationwithagemaybeofimportanceforrefractivesurgery.Theassociationofasteepercorneawithashorterbodystatureandashorteraxiallengthparallelsanassociationbetweenshorterbodylengthandshorteraxiallengthwithoutassociationwithrefractiveerror.Theassociationamongsteepercornea,shorterbodylength,andlowereducationallevelcomplementstheassociationbetweenshorterbodylengthandlowereducationallevel.Thecorrelationbetweensteepercorneaanddeeperanteriorchambermaybeexplainedgeometrically.

FinancialDisclosure(s)

Theauthor(s)havenoproprietaryorcommercialinterestinanymaterialsdiscussedinthisarticle.

ArticleOutline

MaterialsandMethods

Results

Discussion

StudyLimitations

Supplementarydata

References

Purchase

268

Techno-economicevaluationofmembranetechnologyforpre-combustiondecarbonisation:

Water-gasshiftversusreforming  OriginalResearchArticle

EnergyProcedia,Volume4,2011,Pages723-730

JanWilcoDijkstra,GunabalanRaju,GerardPeppink,DanielJansen

 Closepreview  |  

PDF(344K)  |  Relatedarticles  |  Relatedreferenceworkarticles    

AbstractAbstract|ReferencesReferences

Abstract

Atechno-economicevaluationoftheapplicationofmembranereactorsinnaturalgascombinedcycleswithCO2captureispresented.Theelectricalefficiency,captureefficiency,requiredmembranesurfaceareaandcostofCO2avoidedarepresentedforpowerplantsintegratedwithmembranereformersaswellasmembranewatergasshiftreactors.ForapplicationsinCO2capture,membranewater-gas-shiftismoresuitedthanmembranereforming.ThelowerhydrogenpartialpressureinamembranereformercomparedtomembraneWGScauseshighinvestmentcosts,becausethemembraneareaishighandcompressionofthehydrogenfuelbeforeenteringthegasturbineisnecessary.Asignificantincreaseinoperatingtemperature,possiblycombinedwithahigherfeedpressurecouldimprovetheperformanceofmembranereformers.Forthevariousoptionsofupstreamreforminginmembranewater-gasshift,gasheatedreformingisthepreferredoptionwithautothermalreformingassecondbest.

269

RandomizedComparisonofSystemicAnti-inflammatoryTherapyVersusFluocinoloneAcetonideImplantforIntermediate,Posterior,andPanuveitis:

TheMulticenterUveitisSteroidTreatmentTrial  OriginalResearchArticle

Ophthalmology,InPress,CorrectedProof,Availableonline15August2011

TheMulticenterUveitisSteroidTreatment(MUST)TrialResearchGroupWritingCommittee,JohnH.Kempen,MichaelM.Altaweel,JanetT.Holbrook,DouglasA.Jabs,ThomasA.Louis,ElizabethA.Sugar,JenniferE.Thorne

 Closepreview  |  Supplementarycontent

  |  Relatedarticles  |  Relatedreferenceworkarticles    

AbstractAbstract|Figures/TablesFigures/Tables|ReferencesReferences

Objective

Tocomparetherelativeeffectivenessofsystemiccorticosteroidsplusimmunosuppressionwhenindicated(systemictherapy)versusfluocinoloneacetonideimplant(implanttherapy)fornoninfectiousintermediate,posterior,orpanuveitis(uveitis).

Design

Randomizedcontrolledparallelsuperioritytrial.

Participants

Patientswithactiveorrecentlyactiveuveitis.

Methods

Participantswererandomized(allocationratio1:

1)tosystemicorimplanttherapyat23centers(3countries).Implant-assignedparticipantswithbilateraluveitiswereassignedtohaveeacheyethatwarrantedstudytreatmentimplanted.Treatment-outcomeassociationswereanalyzedbyassignedtreatmentforalleyeswithuveitis.

MainOutcomeMeasures

Maskedexaminersmeasuredtheprimaryoutcome:

changeinbest-correctedvisualacuityfrombaseline.Secondaryoutcomesincludedpatient-reportedqualityoflife,ophthalmologist-gradeduveitisactivity,andlocalandsystemiccomplicationsofuveitisortherapy.ReadingCentergradersandglaucomaspecialistsassessingocularcomplicationsweremasked.Participants,ophthalmologists,andcoordinatorswereunmasked.

Results

Onevaluationofchangesfrombaselineto24monthsamong255patientsrandomizedtoimplantandsystemictherapy(479eyeswithuveitis),theimplantandsystemictherapygroupshadanimprovementinvisualacuityof+6.0and+3.2letters(P=0.16,95%confidenceintervalondifferenceinimprovementbetweengroups,−1.2to+6.7letters,positivevaluesfavoringimplant),animprovementinvision-relatedqualityoflifeof+11.4and+6.8units(P=0.043),achangeinEuroQol-EQ5Dhealthutilityof+0.02and−0.02(P=0.060),andresidualactiveuveitisin12%and29%(P=0.001),respectively.Overthe24monthperiod,implant-assignedeyeshadahigherriskofcataractsurgery(80%,hazardratio[HR]=3.3,P<0.0001),treatmentforelevatedintraocularpressure(61%,HR=4.2,P<0.0001),andglaucoma(17%,HR=4.2,P=0.0008).Patientsassignedtosystemictherapyhadmoreprescription-requiringinfectionsthanpatientsassignedtoimplanttherapy(0.60vs0.36/person-year,P=0.034),withoutnotablelong-termconsequences;systemicadverseoutcomesotherwisewereunusualinbothgroups,withminimaldifferencesbetweengroups.

Conclusions

Ineachtreatmentgroup,meanvisualacuityimprovedover24months,withneitherapproachsuperiortoadegreedetectablewiththestudy'spower.Therefore,thespecificadvantagesanddisadvantagesidentifiedshoulddictateselectionbetweenthealternativetreatmentsinconsiderationofindividualpatients'particularcircumstances.Systemictherapywithaggressiveuseofcorticosteroid-sparingimmunosuppressionwaswelltolerated,suggestingthatthisapproachisreasonablysafeforlocalandsystemicinflammatorydisorders.

FinancialDisclosure(s)

Proprietaryorcommercialdisclosuremaybefoundafterthereferences.

ArticleOutline

MaterialsandMethods

StudyDesign

EnrollmentofParticipants,DataCollection,andFollow-up

RandomTreatmentAssignment

Treatment

OutcomesandMasking

SampleSizeDetermination

StatisticalAnalyses

Results

VisualFunction

UveitisActivityandMacularEdema

OcularandSystemicComplications

QualityofLife

Discussion

Supplementarydata

References

Purchase

270

DifferentialImprovementsinLipidProfilesandFraminghamRecurrentRiskScoreinPatientsWithandWithoutDiabetesMellitusUndergoingLong-TermCardiacRehabilitation  OriginalResearchArticle

ArchivesofPhysicalMedicineandRehabilitation,Volume92,Issue9,September2011,Pages1382-1387

SeanCarroll,CostasTsakirides,JamesHobkirk,JamesW.A.Moxon,JamesW.D.Moxon,MichaelDudfield,LeeIngle

 Closepreview  |  Relatedarticles  |  Relatedreferenceworkarticles    

AbstractAbstract|Figures/TablesFigures/Tables|ReferencesReferences

Abstract

CarrollS,TsakiridesC,HobkirkJ,MoxonJWA,MoxonJWD,DudfieldM,IngleL.DifferentialimprovementsinlipidprofilesandFraminghamrecurrentriskscoreinpatientswithandwithoutdiabetesmellitusundergoinglong-termcardiacrehabilitation.

Objective

Todeterminewhetherlipidprofilesandrecurrentcoronaryheartdisease(CHD)riskcouldbemodifiedinpatientswithandwithoutdiabetesmellitusunder

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 人文社科 > 法律资料

copyright@ 2008-2022 冰豆网网站版权所有

经营许可证编号:鄂ICP备2022015515号-1